ATE555384T1 - Verfahren zum testen der reaktion von zellen auf die einwirkung von therapeutika - Google Patents
Verfahren zum testen der reaktion von zellen auf die einwirkung von therapeutikaInfo
- Publication number
- ATE555384T1 ATE555384T1 AT08011630T AT08011630T ATE555384T1 AT E555384 T1 ATE555384 T1 AT E555384T1 AT 08011630 T AT08011630 T AT 08011630T AT 08011630 T AT08011630 T AT 08011630T AT E555384 T1 ATE555384 T1 AT E555384T1
- Authority
- AT
- Austria
- Prior art keywords
- testing
- response
- cells
- action
- therapeutic drugs
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08011630A EP2138844B1 (de) | 2008-06-26 | 2008-06-26 | Verfahren zum Testen der Reaktion von Zellen auf die Einwirkung von Therapeutika |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE555384T1 true ATE555384T1 (de) | 2012-05-15 |
Family
ID=40152534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08011630T ATE555384T1 (de) | 2008-06-26 | 2008-06-26 | Verfahren zum testen der reaktion von zellen auf die einwirkung von therapeutika |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20090325178A1 (de) |
| EP (1) | EP2138844B1 (de) |
| AT (1) | ATE555384T1 (de) |
| CA (1) | CA2670484A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2642276A1 (de) * | 2012-03-22 | 2013-09-25 | Inoviem Scientific | Verfahren zur dynamischen Spektroskopie unter physiologischen Zuständen |
| RU2653442C2 (ru) * | 2015-12-29 | 2018-05-08 | Федеральное государственное бюджетное учреждение науки Институт теоретической и экспериментальной биофизики Российской академии наук (ИТЭБ РАН) | Способ персонифицированного скрининга действия препаратов на лейкозные клетки ex vivo |
| CN106859800B (zh) * | 2017-02-27 | 2018-03-06 | 滨州医学院 | 一种肿瘤种植器 |
| CN112316993B (zh) * | 2020-10-30 | 2022-04-08 | 临沂大学 | 一种单细胞阵列的获取方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023172A (en) * | 1986-07-14 | 1991-06-11 | The Research Foundation Of State University Of New York | Predictive assay for tumor control |
| US5153131A (en) | 1990-12-11 | 1992-10-06 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | High aspect reactor vessel and method of use |
| US4988623A (en) | 1988-06-30 | 1991-01-29 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Rotating bio-reactor cell culture apparatus |
| US5026650A (en) | 1988-06-30 | 1991-06-25 | The United States Of Amercia As Represented By The Administrator Of The National Aeronautics And Space Administration | Horizontally rotated cell culture system with a coaxial tubular oxygenator |
| US5153132A (en) | 1988-06-30 | 1992-10-06 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Three-dimensional co-culture process |
| US5356793A (en) | 1990-03-15 | 1994-10-18 | Nitta Gelatin Inc. | Method for testing the sensitivity of anticancer drug |
| EE04582B1 (et) | 1998-07-06 | 2006-02-15 | Janssen Pharmaceutica N.V. | Farnesüülproteiintransferaasi inhibiitorite kasutamine radiosensibiliseerimisomadustega farmatseutilise kompositsiooni valmistamiseks, mis on ette nähtud kasutamiseks vähi kiiritusravis |
| CN101437549A (zh) | 2006-05-08 | 2009-05-20 | 日立化成工业株式会社 | 通过对薄切肿瘤组织中mRNA表达进行定量测试实体瘤中药物敏感性的方法 |
-
2008
- 2008-06-26 EP EP08011630A patent/EP2138844B1/de active Active
- 2008-06-26 AT AT08011630T patent/ATE555384T1/de active
-
2009
- 2009-06-26 CA CA002670484A patent/CA2670484A1/en not_active Abandoned
- 2009-06-26 US US12/492,630 patent/US20090325178A1/en not_active Abandoned
-
2015
- 2015-09-04 US US14/845,432 patent/US20150377863A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2138844A1 (de) | 2009-12-30 |
| CA2670484A1 (en) | 2009-12-26 |
| US20150377863A1 (en) | 2015-12-31 |
| US20090325178A1 (en) | 2009-12-31 |
| EP2138844B1 (de) | 2012-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011156734A3 (en) | Method of characterizing vascular diseases | |
| DOP2019000287A (es) | Anticuerpos monoclonales contra el inhibidor de la vía del factor tisular (tfpi) | |
| DE602005006990D1 (de) | Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen | |
| AR088514A1 (es) | Inmunoligantes biespecificos dirigidos contra tnf | |
| BR112013020724A2 (pt) | vestimenta para uso por um ser vivo, em que a vestimenta é adaptada para uso para fornecer um mapa da atividade elétrica, sistema, método e programa de computador para fornercer um mapa de atividade elétrica do coração de um ser vivo por meio de sinais elétricos do coração obtidos por uma série de eletrodos da superfície que são dispostos sobre uma superfície externa do ser vivo | |
| TR201903889T4 (tr) | Korneal endotelyal hücreler üreten yönlendirilmiş diferansiyasyona yönelik yöntem. | |
| DE602007005629D1 (de) | Reversibles siRNA-Silencing eines mutierten und endogenen Huntington-Wildtypgens und dessen Anwendung zur Behandlung von Morbus Huntington | |
| AR084373A1 (es) | Composiciones y metodos para la eliminacion de biopeliculas | |
| BRPI1006215A2 (pt) | " anticorpos multiespecíficos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, método de tratamento, método de inibição de uma atividade bíologica e uso do anticorpo " | |
| BR112015023120A2 (pt) | método para identificar um indivíduo com uma doença ou disfunção, método para prever a responsividade de um indivíduo com uma doença ou disfunção, método para determinar a probabilidade de que um indivíduo com uma doença ou disfunção exibirá benefício do tratamento, método para selecionar uma terapia, usos de um antagonista de ligação do eixo pd-l1, ensaio para identificar um indivíduo com uma doença, kit de diagnóstico, método para avaliar uma resposta ao tratamento e método para monitorar a resposta de um indivíduo tratado | |
| CY1119262T1 (el) | Αναλυτικες μεθοδοι και συστοιχιες για χρηση στην ταυτοποιηση παραγοντων που επαγουν ευαισθητοποιηση στο ανθρωπινο δερμα | |
| AR090047A1 (es) | Dominio variable dual de inmunoglobulinas y sus usos | |
| SG10201903822XA (en) | Method for the enrichment of circulating tumor dna | |
| WO2010105275A3 (en) | Method to assess human allograft status from microrna expression levels | |
| AR085397A1 (es) | Combinacion de inhibidores de quinasa y sus usos | |
| WO2010062960A3 (en) | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE | |
| WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
| BR112014015152A2 (pt) | métodos e materiais para a avaliação da perda de heterozigosidade | |
| EA201390147A1 (ru) | Система циркуляции | |
| BR112013009713A2 (pt) | método para identificação de alta produtividade antagonistas microbianos contra patógenos | |
| BRPI0921026A2 (pt) | avaliação do sistema circulatório de um indivíduo | |
| CU20120126A7 (es) | Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi) | |
| CY1115640T1 (el) | Διαγνωση και αγωγη εναντι της σχιζοφρενειας | |
| BRPI1006270A2 (pt) | ''anticorpo anti a5b1, molécula de ácido nucleio isolado, célula hospedeira, método de produção de um anticorpo anti a5b1, imunoconjugado, composição farmacêutica, método de detecção de proteína a5b1, método de tratamento de um indivíduo e kit de detecção de a5b1 | |
| ATE555384T1 (de) | Verfahren zum testen der reaktion von zellen auf die einwirkung von therapeutika |